![](/img/cover-not-exists.png)
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence
Disertori, Marcello, Latini, Roberto, Maggioni, Aldo Pietro, Delise, Pietro, Di Pasquale, Giuseppe, Franzosi, Maria Grazia, Staszewsky, Lidia, Tognoni, GianniVolume:
7
Language:
english
Journal:
Journal of Cardiovascular Medicine
DOI:
10.2459/01.jcm.0000199778.85343.08
Date:
January, 2006
File:
PDF, 135 KB
english, 2006